General Information of the Compound
| Compound ID |
CP0475747
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-amino-N-[(1R)-1-[5-[(1R)-1-formamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H37N7O3
|
||||||||||||||||||
| Molecular Weight |
579.705
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(Cn2c(nnc2[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)[C@@H](Cc2ccccc2)NC=O)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H37N7O3/c1-33(2,34)32(42)37-29(18-24-19-35-27-12-8-7-11-26(24)27)31-39-38-30(28(36-21-41)17-22-9-5-4-6-10-22)40(31)20-23-13-15-25(43-3)16-14-23/h4-16,19,21,28-29,35H,17-18,20,34H2,1-3H3,(H,36,41)(H,37,42)/t28-,29-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DVBPDCTXXKIINT-FQLXRVMXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01155, Growth hormone secretagogue receptor type 1